Codex DNA Analyst Ratings
Codex DNA Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2022 | 199.4% | Keybanc | $8 → $5 | Maintains | Overweight |
| 03/28/2022 | 379.04% | Keybanc | $30 → $8 | Maintains | Overweight |
| 07/13/2021 | 1277.25% | Jefferies | → $23 | Initiates Coverage On | → Buy |
| 07/13/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 07/13/2021 | 1696.41% | Keybanc | → $30 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/09/2022 | 199.4% | Keybanc | 8 美元 → 5 美元 | 維護 | 超重 |
| 03/28/2022 | 379.04% | Keybanc | 30 美元 → 8 美元 | 維護 | 超重 |
| 2021 年 7 月 13 日 | 1277.25% | 傑富瑞集團 | → 23 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2021 年 7 月 13 日 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
| 2021 年 7 月 13 日 | 1696.41% | Keybanc | → 30 美元 | 啓動覆蓋範圍開啓 | → 超重 |
Codex DNA Questions & Answers
法典 DNA 問題與解答
The latest price target for Codex DNA (NASDAQ: DNAY) was reported by Keybanc on November 9, 2022. The analyst firm set a price target for $5.00 expecting DNAY to rise to within 12 months (a possible 199.40% upside). 2 analyst firms have reported ratings in the last year.
Keybanc於2022年11月9日公佈了Codex DNA（納斯達克股票代碼：DNAY）的最新目標股價。該分析公司將目標股價定爲5.00美元，預計DNAY將在12個月內升至12個月內（可能上漲199.40％）。去年有兩家分析公司公佈了評級。
The latest analyst rating for Codex DNA (NASDAQ: DNAY) was provided by Keybanc, and Codex DNA maintained their overweight rating.
Codex DNA（納斯達克股票代碼：DNAY）的最新分析師評級由Keybanc提供，Codex DNA維持增持評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Codex DNA, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Codex DNA was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Codex DNA的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Codex DNA的最新評級是在2022年11月9日提交的，因此您應該預計下一個評級將在2023年11月9日左右公佈。
While ratings are subjective and will change, the latest Codex DNA (DNAY) rating was a maintained with a price target of $8.00 to $5.00. The current price Codex DNA (DNAY) is trading at is $1.67, which is out of the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的法典委員會DNA（DNAY）評級維持不變，目標價爲8.00美元至5.00美元。Codex DNA（DNAY）的當前交易價格爲1.67美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。